98 research outputs found
Influence of Cement Industry on Global Climate Change
The article deals with global climate change for few last decades and establishes relation between CO2 concentration and global climate change. Summarized influence of manufacturing of cement and concrete on worldβs CO2 emission. Effective supplementary cementitious material like fly ash, slag and silica fume were proposed
Use of monitoring system in Ekaterinburg
The monitoring of buildings and structures condition, as well as the timely implementation of corrective actions aimed at the elimination of adverse factors, are the most important aspects that shall be addressed at the construction stage. The usage of monitoring systems makes it possible to monitor the building condition and above that to implement more efficient design solutions in the prospective projects using the results of the analysis of the acquired and design data. In this work the review of a monitoring system installed in a high-rise building located in Ekaterinburg is given. The paper describes the analysis of the natural oscillation frequency and the logarithmic decrement of fundamental tone acquired with the help of accelerometers, and compares the values with the acceptance limits. The process of converting data acquired by strain gauges for the determination of the stress-strain condition of the bearing structures is analysed. The process of comparison of data obtained by the monitoring system of a high-rise building is described. The necessity of the application of the monitoring system is analysed. Β© Published under licence by IOP Publishing Ltd
Maximal and repeated muscular efforts: ergometric and physiological evaluation criteria
The pre-versus post-experimental 5s maximal strength tests of the isometric contractions of rectus femoris found significant progress in the following test rates: peak force by 10.4%; maximal strength by 13.3% and force impulse by 15.5%. The pre-versus post-experimental 1min maximal strength keeping tests found significant progress in the following test rates: peak force by 11.2%; maximal strength by 15.2%; maximal strength reaching time by 14.6%; and the 97% maximal strength reaching time by 15.8
Results of surgical treatment of postinfarction left ventricular aneurysm complicated with ventricular tachycardia with use of 3D-navigation system CARTOβ’
The aim of the research was to study localization of wandering focus and effectiveness of extensive endocardectomy at left ventricular reconstruction in patients with ischemic heart disease (IHD) with postinfarction left ventricular aneurysm (LVA) in combination with ventricular tachycardia (VT). Examined patients besides diagnostic routines had intracardiac electrophysiological examination (EPE) with use of 3D-navigation system CARTOTX (Biosense Webster). During EPE abnormal zones of delayed navigating and zones of double potential with main localization in the area of cacuminal and middle septate segments were found. All patients were divided into two groups: patients of the first group had aortocoronary bypass (ACB) in combination with left ventricular reconstruction completed with extended resection of endocardium with pinch of all cacuminal and middle septate segments; 2 patients of the second group had isolated ACB, 2 patients had ACB with mitral annuloplasty with rim and de Vega plasty of tricuspid valve, 1 patient had percutaneous transluminal coronary angioplasty, 10 patients hadACB in combination with LVA plasty without extended endocardium resection. As the result of the treatment in the first group there were no VT episodes after resection of aneurysm with extended endocardium resection; 33 % of patients in the second group had implantable cardioverter defibrillator, 7 % of the patients had radio frequency ablation of VT nidus, 7 % of the patients had anti-arrhythmic therapy. Taking into consideration that main localization of ectopic nidus in patients with IHD with postinfarction LVA and VT is in the area of cacuminal and middle septate segments, left ventricular reconstruction in these patients needs to be conducted with extended resection of endocardium of these segments
Outbreak of West Nile virus infection, Volgograd Region, Russia, 1999.
From July 25 to October 1, 1999, 826 patients were admitted to Volgograd Region, Russia, hospitals with acute aseptic meningoencephalitis, meningitis, or fever consistent with arboviral infection. Of 84 cases of meningoencephalitis, 40 were fatal. Fourteen brain specimens were positive in reverse transcriptase-polymerase chain reaction assays, confirming the presence of West Nile/Kunjin virus
Genetic Biomarkers of Antipsychotic-Induced Prolongation of the QT Interval in Patients with Schizophrenia.
Antipsychotics (AP) induced prolongation of the QT interval in patients with schizophrenia (Sch) is an actual interdisciplinary problem as it increases the risk of sudden death syndrome. Long QT syndrome (LQTS) as a cardiac adverse drug reaction is a multifactorial symptomatic disorder, the development of which is influenced by modifying factors (APs' dose, duration of APs therapy, APs polytherapy, and monotherapy, etc.) and non-modifying factors (genetic predisposition, gender, age, etc.). The genetic predisposition to AP-induced LQTS may be due to several causes, including causal mutations in the genes responsible for monoheme forms of LQTS, single nucleotide variants (SNVs) of the candidate genes encoding voltage-dependent ion channels expressed both in the brain and in the heart, and SNVs of candidate genes encoding key enzymes of APs metabolism. This narrative review summarizes the results of genetic studies on AP-induced LQTS and proposes a new personalized approach to assessing the risk of its development (low, moderate, high). We recommend implementation in protocols of primary diagnosis of AP-induced LQTS and medication dispensary additional observations of the risk category of patients receiving APs, deoxyribonucleic acid profiling, regular electrocardiogram monitoring, and regular therapeutic drug monitoring of the blood APs levels
Comparative analysis of Illumina and Ion Torrent high-throughput sequencing platforms for identification of plant components in herbal teas
Β© 2018 Elsevier Ltd The rapid development of high-throughput sequencing (HTS) methods offers new opportunities for food quality control and identification of food components using the DNA barcoding approach (metabarcoding in cases of complex mixes). However, the protocols of DNA barcoding applied to food analysis are not yet fully established; testing and optimization are required to achieve the highest accuracy and cost efficiency. We report here a comparative study of the two most widely used sequencing platforms - Illumina and Ion Torrent - for composition analysis of herbal teas, and show that both technologies yield congruent results, both qualitatively and quantitatively. They have revealed the substitution of fireweed (Epilobium angustifolium L.) by Lythrum sp. in one of the samples. It was confirmed by classic methods of botanical analysis (anatomy and palynology). In most samples, undeclared components have been detected, such as bindweed (Convolvulus) and ragweed (Ambrosia), which are known toxic and allergy-causing plants
ΠΠΈΡΡΠ΅ΡΠ΅Π½ΡΠΈΠ°ΡΠΈΡ ΠΈ ΡΡΠ±ΠΏΠΎΠΏΡΠ»ΡΡΠΈΠΎΠ½Π½ΡΠΉ ΡΠΎΡΡΠ°Π² VEGFR2+ ΠΌΠΎΠ½ΠΎΡΠΈΡΠΎΠ² ΠΊΡΠΎΠ²ΠΈ ΠΈ ΠΊΠΎΡΡΠ½ΠΎΠ³ΠΎ ΠΌΠΎΠ·Π³Π° ΠΏΡΠΈ ΠΈΡΠ΅ΠΌΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΊΠ°ΡΠ΄ΠΈΠΎΠΌΠΈΠΎΠΏΠ°ΡΠΈΠΈ
Aim. To identify disturbances of differentiation and subpopulation composition of VEGFR2+ cells in the blood and bone marrow associated with the features of the cytokine profile in the blood and bone marrow in patients with coronary artery disease (CAD) with and without ischemic cardiomyopathy (ICM).Materials and methods. The study included 74 patients with Π‘AD with and without ICM (30 and 44 people, respectively) and 18 healthy donors. In all patients with Π‘AD, peripheral blood sampling was performed immediately before coronary artery bypass grafting, and bone marrow samples were taken during the surgery via a sternal incision. In the healthy donors, only peripheral blood sampling was performed. In the bone marrow and blood samples, the number of VEGFR2+ cells (CD14+VEGFR2+ cells) and their immunophenotypes CD14++CD16-VEGFR2+, CD14++CD16+VEGFR2+, CD14+CD16++VEGFR2+, and CD14+CD16-VEGFR2+ was determined by flow cytometry. Using enzyme-linked immunosorbent assay, the levels of VΠGF-Π, TNFΞ±, M-CSF, and IL-13, as well as the content of MCP-1 (only in the blood) and the M-CSF / IL-13 ratio (only in the bone marrow) were determined.Results. The content of CD14+VEGFR2+ cells in the blood of CAD patients with and without ICM was higher than normal values due to the greater number of CD14++CD16-VEGFR2+, CD14++CD16+VEGFR2+, and CD14+CD16++VEGFR2+. In the bone marrow of the patients with ICM, the content of CD14++CD16-VEGFR2+, CD14+CD16++VEGFR2+, and CD14+CD16-VEGFR2+ was lower than in patients with CAD without ICM, and the number of CD14++CD16+VEGFR2+ cells corresponded to that in the controls. Regardless of the presence of ICM in CAD, a high concentration of TNFΞ± and normal levels of VEGF-A and IL-13 were observed in the blood. In CAD without ICM, an excess of MCP-1 and deficiency of M-CSF were revealed in the blood. In the bone marrow, the levels of VEGF-A, TNFΞ±, M-CSF, and IL-13 were comparable between the groups of patients against the background of a decrease in the M-CSF / IL-13 ratio in the patients with ICM.Conclusion. Unlike CAD without cardiomyopathy, in ICM, no excess of VEGFR2+ cells and MCP-1 in the blood is observed, which hinders active migration of CD14+CD16++VEGFR2+ cells from the myeloid tissue, and a decrease in the M-CSF / IL-13 ratio in the bone marrow disrupts differentiation of other forms of VEGFR2+ cells, preventing vascular repair.Π¦Π΅Π»Ρ: ΡΡΡΠ°Π½ΠΎΠ²ΠΈΡΡ Π½Π°ΡΡΡΠ΅Π½ΠΈΡ Π΄ΠΈΡΡΠ΅ΡΠ΅Π½ΡΠΈΡΠΎΠ²ΠΊΠΈ ΠΈ ΡΡΠ±ΠΏΠΎΠΏΡΠ»ΡΡΠΈΠΎΠ½Π½ΠΎΠ³ΠΎ ΡΠΎΡΡΠ°Π²Π° VEGFR2+ ΠΌΠΎΠ½ΠΎΡΠΈΡΠΎΠ² Π² ΠΊΡΠΎΠ²ΠΈ ΠΈ ΠΊΠΎΡΡΠ½ΠΎΠΌ ΠΌΠΎΠ·Π³Π΅ Π²ΠΎ Π²Π·Π°ΠΈΠΌΠΎΡΠ²ΡΠ·ΠΈ Ρ ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΡΠΌΠΈ ΡΠΈΡΠΎΠΊΠΈΠ½ΠΎΠ²ΠΎΠ³ΠΎ ΠΏΡΠΎΡΠΈΠ»Ρ ΠΊΡΠΎΠ²ΠΈ ΠΈ ΠΊΠΎΡΡΠ½ΠΎΠ³ΠΎ ΠΌΠΎΠ·Π³Π° Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΈΡΠ΅ΠΌΠΈΡΠ΅ΡΠΊΠΎΠΉ Π±ΠΎΠ»Π΅Π·Π½ΡΡ ΡΠ΅ΡΠ΄ΡΠ° (ΠΠΠ‘), ΡΡΡΠ°Π΄Π°ΡΡΠΈΡ
ΠΈ Π½Π΅ ΡΡΡΠ°Π΄Π°ΡΡΠΈΡ
ΠΈΡΠ΅ΠΌΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΊΠ°ΡΠ΄ΠΈΠΎΠΌΠΈΠΎΠΏΠ°ΡΠΈΠ΅ΠΉ (ΠΠΠΠ).ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. Π ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ Π²ΠΎΡΠ»ΠΈ 74 Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΠΠ‘, ΡΡΡΠ°Π΄Π°ΡΡΠΈΡ
ΠΈ Π½Π΅ ΡΡΡΠ°Π΄Π°ΡΡΠΈΡ
ΠΠΠΠ (30 ΠΈ 44 ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ° ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²Π΅Π½Π½ΠΎ), ΠΈ 18 Π·Π΄ΠΎΡΠΎΠ²ΡΡ
Π΄ΠΎΠ½ΠΎΡΠΎΠ². Π£ Π²ΡΠ΅Ρ
Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΠΠ‘ Π·Π°Π±ΠΎΡ ΠΏΠ΅ΡΠΈΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΊΡΠΎΠ²ΠΈ ΠΏΡΠΎΠΈΠ·Π²ΠΎΠ΄ΠΈΠ»ΡΡ Π½Π΅ΠΏΠΎΡΡΠ΅Π΄ΡΡΠ²Π΅Π½Π½ΠΎ ΠΏΠ΅ΡΠ΅Π΄ ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠ΅ΠΉ ΠΊΠΎΡΠΎΠ½Π°ΡΠ½ΠΎΠ³ΠΎ ΡΡΠ½ΡΠΈΡΠΎΠ²Π°Π½ΠΈΡ, Π° ΠΊΠΎΡΡΠ½ΠΎΠ³ΠΎ ΠΌΠΎΠ·Π³Π° β ΠΈΠ· ΡΠ°Π·ΡΠ΅Π·Π° Π³ΡΡΠ΄ΠΈΠ½Ρ Π²ΠΎ Π²ΡΠ΅ΠΌΡ ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΈ. Π£ Π·Π΄ΠΎΡΠΎΠ²ΡΡ
Π΄ΠΎΠ½ΠΎΡΠΎΠ² Π·Π°Π±ΠΈΡΠ°Π»ΠΈ ΡΠΎΠ»ΡΠΊΠΎ ΠΏΠ΅ΡΠΈΡΠ΅ΡΠΈΡΠ΅ΡΠΊΡΡ ΠΊΡΠΎΠ²Ρ.Β Π ΠΊΠΎΡΡΠ½ΠΎΠΌ ΠΌΠΎΠ·Π³Π΅ ΠΈ ΠΊΡΠΎΠ²ΠΈ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΠΏΡΠΎΡΠΎΡΠ½ΠΎΠΉ ΡΠΈΡΠΎΡΠ»ΡΠΎΡΠΈΠΌΠ΅ΡΡΠΈΠΈ ΠΎΠΏΡΠ΅Π΄Π΅Π»ΡΠ»ΠΈ ΡΠΈΡΠ»Π΅Π½Π½ΠΎΡΡΡ VEGFR2+ ΠΌΠΎΠ½ΠΎΡΠΈΡΠΎΠ² (CD14+VΠGFR2+ ΠΊΠ»Π΅ΡΠΎΠΊ) ΠΈ ΠΈΡ
ΠΈΠΌΠΌΡΠ½ΠΎΡΠ΅Π½ΠΎΡΠΈΠΏΠΎΠ² CD14++CD16-VEGFR2+, CD14++CD16+VEGFR2+, CD14+CD16++VEGFR2+, CD14+CD16-VEGFR2+, ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΠΈΠΌΠΌΡΠ½ΠΎΡΠ΅ΡΠΌΠ΅Π½ΡΠ½ΠΎΠ³ΠΎ Π°Π½Π°Π»ΠΈΠ·Π° ΡΠ΅Π³ΠΈΡΡΡΠΈΡΠΎΠ²Π°Π»ΠΈ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΡ VΠGF-Π, TNFΞ±, M-CSF, IL-13, Π° ΡΠ°ΠΊΠΆΠ΅ ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅ MCP-1 (ΡΠΎΠ»ΡΠΊΠΎ Π² ΠΊΡΠΎΠ²ΠΈ) ΠΈ ΡΠΎΠΎΡΠ½ΠΎΡΠ΅Π½ΠΈΠ΅ M-CSF/IL-13 (ΡΠΎΠ»ΡΠΊΠΎ Π² ΠΊΠΎΡΡΠ½ΠΎΠΌ ΠΌΠΎΠ·Π³Π΅).Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. Π‘ΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅ CD14+VEGFR2+ ΠΊΠ»Π΅ΡΠΎΠΊ Π² ΠΊΡΠΎΠ²ΠΈ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΠΠ‘ Π±Π΅Π· ΠΊΠ°ΡΠ΄ΠΈΠΎΠΌΠΈΠΎΠΏΠ°ΡΠΈΠΈ ΠΈ Ρ ΠΠΠΠ Π±ΡΠ»ΠΎ Π²ΡΡΠ΅ Π½ΠΎΡΠΌΡ ΠΈΠ·-Π·Π° Π±ΠΎΠ»ΡΡΠ΅ΠΉ ΡΠΈΡΠ»Π΅Π½Π½ΠΎΡΡΠΈ CD14++CD16-VEGFR2+, CD14++CD16+VEGFR2+ ΠΈ CD14+CD16++VEGFR2+ ΡΠΎΡΠΌ. Π ΠΊΠΎΡΡΠ½ΠΎΠΌ ΠΌΠΎΠ·Π³Π΅ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΠΠΠ ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅ CD14++CD16-VEGFR2+, CD14+CD16++VEGFR2+ ΠΈ CD14+CD16-VEGFR2+ ΡΠΎΡΠΌ Π±ΡΠ»ΠΎ Π½ΠΈΠΆΠ΅, ΡΠ΅ΠΌ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΠΠ‘ Π±Π΅Π· ΠΊΠ°ΡΠ΄ΠΈΠΎΠΌΠΈΠΎΠΏΠ°ΡΠΈΠΈ, Π° ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ²ΠΎ CD14++CD16+VEGFR2+ ΠΊΠ»Π΅ΡΠΎΠΊ ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²ΠΎΠ²Π°Π»ΠΎ ΠΈΡ
ΡΠΈΡΠ»Ρ Π² Π³ΡΡΠΏΠΏΠ΅ ΡΡΠ°Π²Π½Π΅Π½ΠΈΡ. ΠΠ½Π΅ Π·Π°Π²ΠΈΡΠΈΠΌΠΎΡΡΠΈ ΠΎΡ Π½Π°Π»ΠΈΡΠΈΡ ΠΠΠΠ ΠΏΡΠΈ ΠΠΠ‘ Π² ΠΊΡΠΎΠ²ΠΈ ΠΎΡΠΌΠ΅ΡΠ°Π»Π°ΡΡ Π²ΡΡΠΎΠΊΠ°Ρ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΡ TNFΞ±, Π½ΠΎΡΠΌΠ°Π»ΡΠ½ΡΠΉ ΡΡΠΎΠ²Π΅Π½Ρ VEGF-Π ΠΈ IL-13; ΠΏΡΠΈ ΠΠΠ‘ Π±Π΅Π· ΠΊΠ°ΡΠ΄ΠΈΠΎΠΌΠΈΠΎΠΏΠ°ΡΠΈΠΈ β ΠΈΠ·Π±ΡΡΠΎΠΊ ΠΠ‘Π -1 ΠΈ Π΄Π΅ΡΠΈΡΠΈΡ M-CSF Π² ΠΊΡΠΎΠ²ΠΈ. Π ΠΊΠΎΡΡΠ½ΠΎΠΌ ΠΌΠΎΠ·Π³Π΅ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΡ VΠGF-Π, TNFΞ±, M-CSF, IL-13 Π±ΡΠ»Π° ΡΠΎΠΏΠΎΡΡΠ°Π²ΠΈΠΌΠΎΠΉ ΠΌΠ΅ΠΆΠ΄Ρ Π³ΡΡΠΏΠΏΠ°ΠΌΠΈ Π±ΠΎΠ»ΡΠ½ΡΡ
Π½Π° ΡΠΎΠ½Π΅ ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΡ M-CSF/IL-13 Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΠΠΠΠ.ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. Π ΠΎΡΠ»ΠΈΡΠΈΠ΅ ΠΎΡ ΠΠΠ‘ Π±Π΅Π· ΠΊΠ°ΡΠ΄ΠΈΠΎΠΌΠΈΠΎΠΏΠ°ΡΠΈΠΈ ΠΏΡΠΈ ΠΠΠΠ Π½Π΅ ΡΠΎΡΠΌΠΈΡΡΠ΅ΡΡΡ ΠΈΠ·Π±ΡΡΠΎΠΊ VEGFR2+ ΠΌΠΎΠ½ΠΎΡΠΈΡΠΎΠ² ΠΈ ΠΠ‘Π -1 Π² ΠΊΡΠΎΠ²ΠΈ, ΡΡΠΎ Π·Π°ΡΡΡΠ΄Π½ΡΠ΅Ρ Π°ΠΊΡΠΈΠ²Π½ΡΡ ΠΌΠΈΠ³ΡΠ°ΡΠΈΡ CD14+CD16++VEGFR2+ ΠΊΠ»Π΅ΡΠΎΠΊ ΠΈΠ· ΠΌΠΈΠ΅Π»ΠΎΠΈΠ΄Π½ΠΎΠΉ ΡΠΊΠ°Π½ΠΈ, Π° ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΠ΅ M-CSF/IL-13 Π² ΠΊΠΎΡΡΠ½ΠΎΠΌ ΠΌΠΎΠ·Π³Π΅ Π½Π°ΡΡΡΠ°Π΅Ρ Π΄ΠΈΡΡΠ΅ΡΠ΅Π½ΡΠΈΡΠΎΠ²ΠΊΡ ΠΎΡΡΠ°Π»ΡΠ½ΡΡ
ΡΠΎΡΠΌ VEGFR2+ ΠΌΠΎΠ½ΠΎΡΠΈΡΠΎΠ², ΠΏΡΠ΅ΠΏΡΡΡΡΠ²ΡΡ ΡΠ΅ΠΏΠ°ΡΠ°ΡΠΈΠΈ ΡΠΎΡΡΠ΄ΠΎΠ²
The Use of Sutureless Electrosurgical and Ultrasound Technologies in Lung Surgeries β Literature Review
ΠΠ° ΡΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΠΌ ΡΡΠΎΠ²Π½Π΅ ΡΠ°Π·Π²ΠΈΡΠΈΡ Π²ΠΈΠ΄Π΅ΠΎΡΠΎΡΠ°ΠΊΠΎΡΠΊΠΎΠΏΠΈΡΠ΅ΡΠΊΠΎΠΉ Ρ
ΠΈΡΡΡΠ³ΠΈΠΈ Π»Π΅Π³ΠΊΠΈΡ
ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ Π²ΡΠ±ΠΎΡΠ° ΡΠ²Π»ΡΠ΅ΡΡΡ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ ΡΠ½Π΄ΠΎΡΡΠ΅ΠΏΠ»Π΅ΡΠΎΠ² (ΠΠ‘), ΠΎΡΡΡΠ΅ΡΡΠ²Π»ΡΡΡΠΈΡ
ΠΎΠ΄Π½ΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΠ΅ ΠΏΡΠΎΡΠΈΠ²Π°Π½ΠΈΠ΅ ΠΈ ΡΠ°ΡΡΠ΅ΡΠ΅Π½ΠΈΠ΅ Π»Π΅Π³ΠΎΡΠ½ΠΎΠΉ ΡΠΊΠ°Π½ΠΈ ΠΌΠ΅ΠΆΠ΄Ρ Π½Π°Π»ΠΎΠΆΠ΅Π½Π½ΡΠΌ ΡΡΠ΄ΠΎΠΌ ΡΠ°Π½ΡΠ°Π»ΠΎΠ²ΡΡ
ΡΠΊΠΎΠ±ΠΎΠΊ. ΠΠ΄Π½Π°ΠΊΠΎ ΡΠΈΡΠΎΠΊΠΎΠ΅ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ ΠΠ‘ ΠΏΠΎΠΊΠ°Π·Π°Π»ΠΎ, ΡΡΠΎ ΠΌΠ΅Ρ
Π°Π½ΠΈΡΠ΅ΡΠΊΠΈΠΉ ΡΠΎΠ² Π½Π΅ Π²ΡΠ΅Π³Π΄Π° ΠΎΠ±Π΅ΡΠΏΠ΅ΡΠΈΠ²Π°Π΅Ρ Π½Π°Π΄Π΅ΠΆΠ½ΡΠΉ Π°ΡΡΠΎΡΡΠ°Π·, ΡΡΠΎ Π·Π°ΡΡΠ°Π²Π»ΡΠ΅Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°ΡΡ Π΄ΠΎΠΏΠΎΠ»Π½ΠΈΡΠ΅Π»ΡΠ½ΡΠ΅ ΡΠΈΠ½ΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΌΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ. ΠΡΠΎΠΌΠ΅ ΡΠΎΠ³ΠΎ, Π½Π΅Π΄ΠΎΡΡΠ°ΡΠΊΠ°ΠΌΠΈ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΡ ΠΠ‘ ΡΠ²Π»ΡΠ΅ΡΡΡ ΠΈΡ
Π²ΡΡΠΎΠΊΠ°Ρ ΡΠ΅Π½Π°, ΠΏΠΎΡΡΠ΅Π±Π½ΠΎΡΡΡ Π² ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠΈ Π½Π΅ΡΠΊΠΎΠ»ΡΠΊΠΈΡ
ΠΊΠ°ΡΡΡΠΈΠ΄ΠΆΠ΅ΠΉ, ΠΏΠΎΡΡΡΠ΅Π·Π΅ΠΊΡΠΈΠΎΠ½Π½ΠΎΠ΅ Π²ΡΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅ ΠΈΠ· Π΄ΡΡ
Π°Π½ΠΈΡ Π½Π΅ΠΈΠ·ΠΌΠ΅Π½Π΅Π½Π½ΡΡ
ΡΡΠ°ΡΡΠΊΠΎΠ² Π»Π΅Π³ΠΎΡΠ½ΠΎΠΉ ΠΏΠ°ΡΠ΅Π½Ρ
ΠΈΠΌΡ, Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΡΠ΅ ΡΡΡΠ΄Π½ΠΎΡΡΠΈ Π² ΡΠ°Π·ΠΌΠ΅ΡΠ΅Π½ΠΈΠΈ ΡΠ°Π±ΠΎΡΠ΅ΠΉ ΡΠ°ΡΡΠΈ Π°ΠΏΠΏΠ°ΡΠ°ΡΠ° Π² ΠΏΠ»Π΅Π²ΡΠ°Π»ΡΠ½ΠΎΠΉ ΠΏΠΎΠ»ΠΎΡΡΠΈ, Π±ΠΎΠ»ΡΡΠΎΠΉ Π΄ΠΈΠ°ΠΌΠ΅ΡΡ ΡΠΎΡΠ°ΠΊΠΎΠΏΠΎΡΡΠ° (Π’), Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΡΠΉ Π΄Π»Ρ Π²Π²Π΅Π΄Π΅Π½ΠΈΡ ΠΠ‘.The review presents data of the use of electric seal and ultrasonic technology in the performance of open and videothoracoscopic lung resections. The possibility of seamless resection of the lung tissue by using bipolar electric seal (LigaSure) and ultrasonic (Harmonic) scalpel with tolerable aerohemostasis shown. The advantages and possible drawbacks of these methods displayed
Production of angiogenesis mediators and the structure of the vascular wall in the heart in ischemic cardiomyopathy
Background. In the pathogenesis of ischemic cardiomyopathy (ICMP), angiopoiesis remains unexplored.The aim. To describe the vasculature of the heart and the imbalance of angiogenesis mediators in the coronary circulation in association with the number of endothelial progenitor cells (EPC) and desquamated endothelial cells (DEC) in the blood of patients with coronary heart disease (CHD), suffering and not suffering from ICMP.Methods. Fifty-two patients with CHD (30 Β patients with ICMP, 22 Β patients without Β ICMP), 15 Β healthy donors were examined. The content of EPC (CD14+CD34+VEGFR2+) in the blood from the cubital vein and DEC (CD45βCD146+) in the blood from the coronary sinus and the cubital vein was determined by flow cytometry. The concentrations of VEGF-A (vascular endothelial growth factor A), PDGF (platelet-derived growth factor), and SDF-1 (stromal cell-derived factor 1) in blood plasma were recorded using immunofluorescence assay; the angiopoietin-2, MMP-9 (matrix metallopeptidase 9) were recorded using enzyme immunoassay. In myocardial biopsies the specific area of vessels and the expression of Ξ±SMA (smooth muscle alpha-actin) were determined by morphometric and immunohistochemical methods.Results. In the peripheral blood of patients with CHD, regardless of the presence of ICMP, the DEC content exceeded the physiological level, and the VEGF-A, PDGF, angiopoietin-2, and MMP-9 corresponded to the norm. In CHD patients without cardiomyopathy, there was an excess of SDF-1 and EPC in the blood from the cubital vein, and in ICMP, their physiological significance was noted. In the coronary blood flow in patients with CHD without cardiomyopathy, an increase in the concentration of PDGF was found, which was not determined in patients with ICMP, who had an increased content of DEC, angiopoietin-2 and MMP-9. The specific area of the vessels in the patients of the two groups was comparable; the expression of Ξ±SMA in ICMP was 6.2 times lower than in patients with CHD without cardiomyopathy.Conclusion. The development of ICMP is accompanied by impaired maturation of vessels in the myocardium, associated with the absence of a compensatory reaction of activation of cellular and humoral factors of angiogenesis
- β¦